XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 443,772 $ 159,662
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation, depletion and amortization 188,405 167,038
Deferred income tax expense 152,647 66,976
Loss on sale of assets 1,500 40,505
Exploratory dry hole cost 16 51,085
Gain on derivative instruments (71,906) (1,909)
Net cash received (paid) in settlement of derivative instruments 68,377 (20,312)
(Earnings) loss on equity method investments (7,334) 998
Distribution of earnings from equity method investments 8,750 0
Amortization of debt issuance costs 2,464 2,390
Stock-based compensation and other 21,058 10,364
Changes in assets and liabilities:    
Accounts receivable, net 179,027 38,939
Income taxes (5,577) 12,107
Inventories (8,305) (12,377)
Other current assets (2,263) (1,096)
Accounts payable and accrued liabilities (35,867) 7,168
Interest payable (216) (215)
Other assets and liabilities (22,611) 25,337
Net cash provided by operating activities 911,937 546,660
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (421,500) (387,271)
Proceeds from sale of assets 2,346 646,868
Investment in equity method investments (5,131) (62,905)
Distribution of investment from equity method investments 758 0
Net cash (used in) provided by investing activities (423,527) 196,692
CASH FLOWS FROM FINANCING ACTIVITIES    
Borrowings from debt 95,000 0
Repayments of debt (102,000) 0
Treasury stock repurchases (156,638) (419,654)
Dividends paid (67,697) (54,718)
Tax withholdings on vesting of stock awards (10,557) (8,033)
Capitalized debt issuance costs (7,411) 0
Net cash used in financing activities (249,303) (482,405)
Net increase in cash and cash equivalents 239,107 260,947
Cash and cash equivalents, beginning of period 2,287 480,047
Cash and cash equivalents, end of period $ 241,394 $ 740,994